These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


452 related items for PubMed ID: 31778139

  • 1. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB, Wang S, He X, Tang W, Wang J, Shao A, Zhang J.
    J Mater Chem B; 2019 Dec 11; 7(48):7683-7689. PubMed ID: 31778139
    [Abstract] [Full Text] [Related]

  • 2. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.
    Jiang Z, Wang Y, Sun L, Yuan B, Tian Y, Xiang L, Li Y, Li Y, Li J, Wu A.
    Biomaterials; 2019 Mar 11; 197():41-50. PubMed ID: 30640136
    [Abstract] [Full Text] [Related]

  • 3. Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies.
    Wu W, Yu X, Sun J, Han Y, Ma Y, Zhang G, Ma Q, Li Q, Xiang H.
    Int J Nanomedicine; 2023 Mar 11; 18():7985-7999. PubMed ID: 38164268
    [Abstract] [Full Text] [Related]

  • 4. Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy against non-small-cell lung cancer.
    Lu K, Pan X, Zheng J, Cheng D, Zheng L, Zhang X.
    J Mater Sci Mater Med; 2024 Jun 19; 35(1):32. PubMed ID: 38896160
    [Abstract] [Full Text] [Related]

  • 5. Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles.
    Jiang H, Bao Q, Yang T, Yang M, Mao C.
    ACS Appl Mater Interfaces; 2024 Sep 18; 16(37):49003-49012. PubMed ID: 39226043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V, Naeimi H, Goliaei B, Bigdeli B, Sadighi A, Dehghani S, Lotfabadi A, Hosseini M, Nezamtaheri MS, Amanlou M, Sharifzadeh M, Khoobi M.
    Mater Sci Eng C Mater Biol Appl; 2019 Jun 18; 99():805-815. PubMed ID: 30889755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bimetallic Zeolitic Imidazolate Framework as an Intrinsic Two-Photon Fluorescence and pH-Responsive MR Imaging Agent.
    Zhao G, Wu H, Feng R, Wang D, Xu P, Wang H, Guo Z, Chen Q.
    ACS Omega; 2018 Aug 31; 3(8):9790-9797. PubMed ID: 31459108
    [Abstract] [Full Text] [Related]

  • 11. Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells.
    Ren C, Tu Q, He J.
    J Biomater Sci Polym Ed; 2024 Sep 31; 35(13):1978-1998. PubMed ID: 38953298
    [Abstract] [Full Text] [Related]

  • 12. Tandem post-synthetic modification of a zeolitic imidazolate framework for CXCR4-overexpressed esophageal squamous cell cancer imaging and therapy.
    Cao Y, Jiang Z, Li Y, Wang Y, Yang Y, Akakuru OU, Li J, Wu A.
    Nanoscale; 2020 Jun 28; 12(24):12779-12789. PubMed ID: 32347269
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor microenvironment responsive T1-T2 dual-mode contrast agent Fe3O4@ZIF-8-Zn-Mn NPs for in vivo magnetic resonance imaging.
    Liang M, Zhou W, Zhang H, Zheng J, Lin J, An L, Yang S.
    J Mater Chem B; 2023 May 17; 11(19):4203-4210. PubMed ID: 37114335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization.
    Maleki A, Shahbazi MA, Alinezhad V, Santos HA.
    Adv Healthc Mater; 2020 Jun 17; 9(12):e2000248. PubMed ID: 32383250
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.